Morning Breakouts

Latest California Healthline Stories

Average Consumer Unlikely To Get Any Benefit From Pfizer’s Decision To Roll Back Steep Drug Increases

The company won glowing praise from the White House after it decided to delay its price hikes, but experts say the move is not going to make a big difference to any of the players involved — including the consumers. Meanwhile, congressional Democrats want more information on the deal between Pfizer and President Donald Trump.

Under Pressure, Trump Administration Expected To Streamline Process Of Reuniting Separate Families

To speed up the reunions, the government will no longer insist on fingerprinting all adults in a household where a child will live, or require home visits by a social worker. Meanwhile, tech issues aren’t helping the problems. And lawmakers’ tarrying at a House Appropriations Committee highlights just how hard it will be to pass immigration measures in this Congress.

Health Care A Talking Point In Democrats’ Kavanaugh Strategy. But So Are Unions And Guns And LGBTQ Rights And …

Where as the GOP has picked one message to focus on for the Supreme Court nomination battle — Brett Kavanaugh’s credentials — Democrats are being pulled in a lot of different directions. “We have a long history of making simple arguments overly complicated, and we have a long history of thinking that we need to compartmentalize our messages for different groups,” said Sen. Chris Murphy (D-Conn.). “We need to get over both of those addictions if we are going to defeat Brett Kavanaugh.”

Following Financial Troubles, Allegations Of Fraud, Addiction Treatment Center Sovereign Health To Close

In June 2017, FBI agents along with federal and state officials served search warrants at Sovereign’s headquarters and other locations. Though officials haven’t said why they are investigating the company, the raids came following civil lawsuits involving Sovereign and Health Net over allegations that the health company overcharged the insurance carrier.

Pfizer To Temporarily Roll Back Drug Price Increases Following Talk With Trump

The company came under fire from President Donald Trump and others when it announced steep price hikes on many of their drugs. “Pfizer & others should be ashamed that they have raised drug prices for no reason,” Trump said in a tweet prior to the company’s about-face. “They are merely taking advantage of the poor & others unable to defend themselves, while at the same time giving bargain basement prices to other countries in Europe & elsewhere. We will respond!”

Nominee For VA Secretary Chief Sails Through Committee And Is Headed For Full Senate Confirmation

Robert Wilkie was grilled during his confirmation hearing about whether he will seek to privatize the troubled Veterans Affairs Department. He promised that he won’t. Sen. Bernie Sanders (I-Vt.) was the only lawmaker on the Senate Veterans Affairs Committee to vote against Wilkie.